Home Cart Sign in  
Chemical Structure| 4344-87-0 Chemical Structure| 4344-87-0
Chemical Structure| 4344-87-0

5-Methyl-1H-pyrazol-3(2H)-one

CAS No.: 4344-87-0

4.5 *For Research Use Only !

Cat. No.: A101431 Purity: 98%

Change View

Size Price

US Stock

Global Stock

In Stock
10g łÇʶÊÊ Inquiry Inquiry
25g łÇ˶ÊÊ Inquiry Inquiry
100g łËͶÊÊ Inquiry Inquiry
500g łóó¶ÊÊ Inquiry Inquiry

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 10g

    łÇʶÊÊ

  • 25g

    łÇ˶ÊÊ

  • 100g

    łËͶÊÊ

  • 500g

    łóó¶ÊÊ

In Stock

- +

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support Online Technical Q&A
Product Citations

Alternative Products

Product Details of [ 4344-87-0 ]

CAS No. :4344-87-0
Formula : C4H6N2O
M.W : 98.10
SMILES Code : O=C1NNC(C)=C1
MDL No. :MFCD00010705
InChI Key :WGVHNCAJPFIFCR-UHFFFAOYSA-N
Pubchem ID :319771

Safety of [ 4344-87-0 ]

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Calculated chemistry of [ 4344-87-0 ] Show Less

Physicochemical Properties

Num. heavy atoms 7
Num. arom. heavy atoms 5
Fraction Csp3 0.25
Num. rotatable bonds 0
Num. H-bond acceptors 1.0
Num. H-bond donors 2.0
Molar Refractivity 26.38
TPSA ?

Topological Polar Surface Area: Calculated from
Ertl P. et al. 2000 J. Med. Chem.

48.65 Ų

Lipophilicity

Log Po/w (iLOGP)?

iLOGP: in-house physics-based method implemented from
Daina A et al. 2014 J. Chem. Inf. Model.

0.82
Log Po/w (XLOGP3)?

XLOGP3: Atomistic and knowledge-based method calculated by
XLOGP program, version 3.2.2, courtesy of CCBG, Shanghai Institute of Organic Chemistry

0.11
Log Po/w (WLOGP)?

WLOGP: Atomistic method implemented from
Wildman SA and Crippen GM. 1999 J. Chem. Inf. Model.

0.01
Log Po/w (MLOGP)?

MLOGP: Topological method implemented from
Moriguchi I. et al. 1992 Chem. Pharm. Bull.
Moriguchi I. et al. 1994 Chem. Pharm. Bull.
Lipinski PA. et al. 2001 Adv. Drug. Deliv. Rev.

-0.22
Log Po/w (SILICOS-IT)?

SILICOS-IT: Hybrid fragmental/topological method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

1.65
Consensus Log Po/w?

Consensus Log Po/w: Average of all five predictions

0.47

Water Solubility

Log S (ESOL):?

ESOL: Topological method implemented from
Delaney JS. 2004 J. Chem. Inf. Model.

-1.05
Solubility 8.82 mg/ml ; 0.0899 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Very soluble
Log S (Ali)?

Ali: Topological method implemented from
Ali J. et al. 2012 J. Chem. Inf. Model.

-0.69
Solubility 20.2 mg/ml ; 0.206 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Very soluble
Log S (SILICOS-IT)?

SILICOS-IT: Fragmental method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

-1.45
Solubility 3.5 mg/ml ; 0.0357 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Soluble

Pharmacokinetics

GI absorption?

Gatrointestinal absorption: according to the white of the BOILED-Egg

High
BBB permeant?

BBB permeation: according to the yolk of the BOILED-Egg

No
P-gp substrate?

P-glycoprotein substrate: SVM model built on 1033 molecules (training set)
and tested on 415 molecules (test set)
10-fold CV: ACC=0.72 / AUC=0.77
External: ACC=0.88 / AUC=0.94

No
CYP1A2 inhibitor?

Cytochrome P450 1A2 inhibitor: SVM model built on 9145 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.83 / AUC=0.90
External: ACC=0.84 / AUC=0.91

No
CYP2C19 inhibitor?

Cytochrome P450 2C19 inhibitor: SVM model built on 9272 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.80 / AUC=0.86
External: ACC=0.80 / AUC=0.87

No
CYP2C9 inhibitor?

Cytochrome P450 2C9 inhibitor: SVM model built on 5940 molecules (training set)
and tested on 2075 molecules (test set)
10-fold CV: ACC=0.78 / AUC=0.85
External: ACC=0.71 / AUC=0.81

No
CYP2D6 inhibitor?

Cytochrome P450 2D6 inhibitor: SVM model built on 3664 molecules (training set)
and tested on 1068 molecules (test set)
10-fold CV: ACC=0.79 / AUC=0.85
External: ACC=0.81 / AUC=0.87

No
CYP3A4 inhibitor?

Cytochrome P450 3A4 inhibitor: SVM model built on 7518 molecules (training set)
and tested on 2579 molecules (test set)
10-fold CV: ACC=0.77 / AUC=0.85
External: ACC=0.78 / AUC=0.86

No
Log Kp (skin permeation)?

Skin permeation: QSPR model implemented from
Potts RO and Guy RH. 1992 Pharm. Res.

-6.82 cm/s

Druglikeness

Lipinski?

Lipinski (Pfizer) filter: implemented from
Lipinski CA. et al. 2001 Adv. Drug Deliv. Rev.
MW ≤ 500
MLOGP ≤ 4.15
N or O ≤ 10
NH or OH ≤ 5

0.0
Ghose?

Ghose filter: implemented from
Ghose AK. et al. 1999 J. Comb. Chem.
160 ≤ MW ≤ 480
-0.4 ≤ WLOGP ≤ 5.6
40 ≤ MR ≤ 130
20 ≤ atoms ≤ 70

None
Veber?

Veber (GSK) filter: implemented from
Veber DF. et al. 2002 J. Med. Chem.
Rotatable bonds ≤ 10
TPSA ≤ 140

0.0
Egan?

Egan (Pharmacia) filter: implemented from
Egan WJ. et al. 2000 J. Med. Chem.
WLOGP ≤ 5.88
TPSA ≤ 131.6

0.0
Muegge?

Muegge (Bayer) filter: implemented from
Muegge I. et al. 2001 J. Med. Chem.
200 ≤ MW ≤ 600
-2 ≤ XLOGP ≤ 5
TPSA ≤ 150
Num. rings ≤ 7
Num. carbon > 4
Num. heteroatoms > 1
Num. rotatable bonds ≤ 15
H-bond acc. ≤ 10
H-bond don. ≤ 5

2.0
Bioavailability Score?

Abbott Bioavailability Score: Probability of F > 10% in rat
implemented from
Martin YC. 2005 J. Med. Chem.

0.55

Medicinal Chemistry

PAINS?

Pan Assay Interference Structures: implemented from
Baell JB. & Holloway GA. 2010 J. Med. Chem.

0.0 alert
Brenk?

Structural Alert: implemented from
Brenk R. et al. 2008 ChemMedChem

0.0 alert: heavy_metal
Leadlikeness?

Leadlikeness: implemented from
Teague SJ. 1999 Angew. Chem. Int. Ed.
250 ≤ MW ≤ 350
XLOGP ≤ 3.5
Num. rotatable bonds ≤ 7

No; 1 violation:MW<1.0
Synthetic accessibility?

Synthetic accessibility score: from 1 (very easy) to 10 (very difficult)
based on 1024 fragmental contributions (FP2) modulated by size and complexity penaties,
trained on 12'782'590 molecules and tested on 40 external molecules (r2 = 0.94)

1.21

Application In Synthesis of [ 4344-87-0 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 4344-87-0 ]

[ 4344-87-0 ] Synthesis Path-Downstream   1~1

  • 1
  • [ 67515-59-7 ]
  • [ 4344-87-0 ]
  • 3-(4-cyano-2-trifluoromethylphenyloxy)-5-methylpyrazole [ No CAS ]
YieldReaction ConditionsOperation in experiment
42.4% With potassium carbonate; In DMF (N,N-dimethyl-formamide); at 80℃; for 6h; Potassium carbonate (2.8 g, 20.0 mmol) was added to a solution of 3-hydroxy-5-methylpyrazole (1.47 g, 15.0 mmol) and <strong>[67515-59-7]4-fluoro-3-trifluoromethylbenzonitrile</strong> (2.8 g, 15.0 mmol) in DMF (30 ml), and the mixture was stirred under heating at 80C for 6 hours. After completion of the reaction, the reaction mixture was poured into 2N hydrochloric acid (70 ml) and extracted with ethyl acetate (30 ml x 3). An organic layer was washed with water, dried over anhydrous magnesium sulfate and filtered to remove a desiccant, and the solvent was distilled off from the filtrate under reduced pressure. The resultant crude product was purified with a silica gel column (ethyl acetate/hexane = 1/5), to give a yellowish solid of 3-(4-cyano-2-trifluoromethylphenyloxy)-5-methylpyrazole (1.7 g, yield: 42.4 %). mp: 123-125C; 1H-NMR(CDCl3, TMS, ppm): delta 2.28(d, J=0.5Hz, 3H), 5.75(d, J=0.5Hz, 1H), 7.30(d, J=8.8Hz, 1H), 7.75(dd, J=2.0 and 8.8Hz, 1H), 7.96(d, J=2.0Hz, 1H), 9.60-11.60(br s, 1H).
 

Historical Records

Technical Information

Categories

Related Functional Groups of
[ 4344-87-0 ]

Amides

Chemical Structure| 137-45-1

A124366 [137-45-1]

1H-Pyrazol-3(2H)-one

Similarity: 0.84

Chemical Structure| 114-83-0

A512291 [114-83-0]

1-Acetyl-2-phenylhydrazine

Similarity: 0.78

Chemical Structure| 52867-35-3

A143956 [52867-35-3]

1-Methyl-1H-pyrazol-3(2H)-one

Similarity: 0.76

Chemical Structure| 59942-87-9

A171024 [59942-87-9]

Pyrazolo[1,5-a]pyridin-2(1H)-one

Similarity: 0.73

Chemical Structure| 28491-52-3

A246130 [28491-52-3]

5-Amino-1H-pyrazol-3(2H)-one

Similarity: 0.72

Related Parent Nucleus of
[ 4344-87-0 ]

Pyrazoles

Chemical Structure| 137-45-1

A124366 [137-45-1]

1H-Pyrazol-3(2H)-one

Similarity: 0.84

Chemical Structure| 52867-35-3

A143956 [52867-35-3]

1-Methyl-1H-pyrazol-3(2H)-one

Similarity: 0.76

Chemical Structure| 28491-52-3

A246130 [28491-52-3]

5-Amino-1H-pyrazol-3(2H)-one

Similarity: 0.72

Chemical Structure| 1008-79-3

A141645 [1008-79-3]

1-Phenyl-1H-pyrazol-3(2H)-one

Similarity: 0.72

Chemical Structure| 89363-91-7

A225921 [89363-91-7]

4-Bromo-5-methyl-1H-pyrazol-3(2H)-one

Similarity: 0.70